Effects of Oral Doxofylline and Procaterol on Chronic Obstructive Pulmonary Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

November 15, 2024

Conditions
COPD
Interventions
DRUG

Doxofylline

Each patient received 4 weeks of treatment with either doxofylline or procaterol followed by a 2-week washout period, and then 4 weeks of treatment with the other drug.

DRUG

Procaterol

Each patient received 4 weeks of treatment with either doxofylline or procaterol followed by a 2-week washout period, and then 4 weeks of treatment with the other drug.

Trial Locations (1)

12120

Narongkorn Saiphoklang, Klongluang

All Listed Sponsors
lead

Thammasat University

OTHER

NCT06346691 - Effects of Oral Doxofylline and Procaterol on Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter